Mon 5 mg (Chewable Tablet)

Indications

• Prophylaxis and chronic treatment of asthma
• Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
• Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis

Pharmacology

• Selective and orally active leukotriene receptor antagonist
• Inhibition of the cysteinyl leukotriene receptor (CysLT1)
• Correlation with the pathophysiology of asthma & allergic rhinitis

Dosage & Administration

• Dosage for adults and adolescents: Montelukast 10 mg tablet once daily
• Dosage for pediatric patients 6 to 14 years of age: Montelukast 5 mg tablet once daily
• Dosage for pediatric patients 2 years to 5 years of age: Montelukast 4 mg tablet once daily
• Dosage for pediatric patients 6 months to 5 years of age: Montelukast 4 mg oral granules once daily

Interaction

• No clinically important effects on the pharmacokinetics of several drugs
• Used concomitantly with a wide range of commonly prescribed drugs without evidence of clinical adverse interactions

Contraindications

• Hypersensitivity to any component of this product

Side Effects

• Common: Diarrhea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
• Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, hemorrhage, irritability, malaise, muscle complaints, edema, seizure, abnormal sensation, sleep disorders
• Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor

Pregnancy & Lactation

• Crosses the placenta following oral dosing in rats and rabbits
• Use during pregnancy only if clearly needed
• Caution should be exercised when given to a nursing mother

Precautions & Warnings

• Not indicated for use in the reversal of bronchospasm in acute asthma attacks
• Can be continued during acute exacerbations of asthma
• Should not be abruptly substituted for inhaled or oral corticosteroids
• Not to be used as monotherapy for the treatment and management of exercise-induced bronchospasm
• Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Montelukast

Overdose Effects

• No adverse experiences in the majority of overdosage reports
• Usual supportive measures should be employed in the event of overdose

Therapeutic Class

• Leukotriene receptor antagonists

Storage Conditions

• Store in cool & dry place below 30°C, protect from light & moisture
• Keep out of reach of children

Chemical Structure

• Molecular Formula: C35H36ClNO3S
• Chemical Structure: Image available

Common Questions about Mon 5 mg Chewable Tablet

• Used to treat asthma or allergic rhinitis
• Effect can be observed after 1-3 hours of administration
• Effect lasts for an average duration of 24 hours
• May be taken with or without food as prescribed by a doctor
• Use in pregnant women should be avoided unless clearly needed

Related Brands

• Mon 10 mg (Tablet) - benham-pharmaceuticals-ltd
• Centokast 10 mg (Tablet) - centeon-pharma-ltd
• Brocast 10 mg (Tablet) - concord-pharmaceuticals-ltd
• Breasy 10 mg (Tablet) - cosmic-pharma-ltd
• Mon-X 10 mg (Tablet) - desh-pharmaceuticals-ltd